2Vannucchi AM, Guglielmelli P, Teffefi A. Advances in understanding and management of myeloproliferative neoplasms [ J ]. CA Cancer J Clin,2009,59(3) :171 -191.
2Ross L, Levine, Mark Heaney. New advances in the pathogenesis and therapy of essential thrombocythemia. Hematology-Amer ican Society of Hematology, 2008,76-82.
3Chloe James. The JAK2V617F Mutation in Polycythemia Vera and Other Myeloproliferative Disorders=One Mutation for Three Diseases? Hematology-American Society of Hematology, 2008, 2008 : 69.
9Jerry L, Spivak, Richard T. Silver. The revised World Health Organization diagnostic criteria for polycythemia vera, essential thrombocytosis, and primary myelofibrosis: an alternative pro-posal, blood,2008, 112:231.
10Uchiyama S,Yamazaki M,Hara Y,et al.Alterations of platelet,coagulation,and fibrinolysis markers in patients with acute ischemic stroke seminn[J].Thromb Hemost,1997,23(6):535-541.
